The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Clover Health Investments Corp (NASDAQ: CLOV) closed at $3.67 in the last session, up 1.10% from day before closing price of $3.63. In other words, the price has increased by $1.10 from its previous closing price. On the day, 6.52 million shares were traded. CLOV stock price reached its highest trading level at $3.8 during the session, while it also had its lowest trading level at $3.56.
Ratios:
We take a closer look at CLOV’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on December 17, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On October 07, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $4.
Cowen Upgraded its Underperform to Market Perform on February 02, 2022, whereas the target price for the stock was revised from $7 to $3.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Edwards Carladenise Armbrister sold 200,000 shares for $3.61 per share. The transaction valued at 722,000 led to the insider holds 273,227 shares of the business.
Priest Brady Patrick sold 75,000 shares of CLOV for $276,000 on Mar 06 ’25. The CEO of Home Care now owns 2,418,151 shares after completing the transaction at $3.68 per share. On Mar 06 ’25, another insider, Soares Karen, who serves as the General Counsel & Secretary of the company, sold 52,500 shares for $3.80 each. As a result, the insider received 199,500 and left with 1,299,663 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLOV now has a Market Capitalization of 1875028736 and an Enterprise Value of 1479764352. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.37 while its Price-to-Book (P/B) ratio in mrq is 5.22. Its current Enterprise Value per Revenue stands at 1.08 whereas that against EBITDA is -33.181.
Stock Price History:
The Beta on a monthly basis for CLOV is 1.97, which has changed by 4.477612 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, CLOV has reached a high of $4.87, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -6.84%, while the 200-Day Moving Average is calculated to be 13.05%.
Shares Statistics:
According to the various share statistics, CLOV traded on average about 6.32M shares per day over the past 3-months and 7256530 shares per day over the past 10 days. A total of 395.74M shares are outstanding, with a floating share count of 383.18M. Insiders hold about 25.00% of the company’s shares, while institutions hold 18.20% stake in the company. Shares short for CLOV as of 1741910400 were 13140400 with a Short Ratio of 1.91, compared to 1739491200 on 15327893. Therefore, it implies a Short% of Shares Outstanding of 13140400 and a Short% of Float of 3.19.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
